Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784875 · ClinicalTrials.gov registry record · Phase 2
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 643
- Enrollment target
NCT00784875 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 643 participants.
The verdict
NCT00784875, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 643 participants
- Enrollment target
Study Summary
The purpose of this study is to compare an investigational drug (LY2624803) with placebo and with zolpidem in the treatment of outpatients with chronic insomnia.
Interventions
- DRUG Placebo
- DRUG zolpidem
- DRUG LY2624803
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 643 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00784875
The ClinicalTrials.gov registry entry for NCT00784875 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 643 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00784875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00784875 about?
NCT00784875 is a clinical study titled "An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia". The purpose of this study is to compare an investigational drug (LY2624803) with placebo and with zolpidem in the treatment of outpatients with chronic insomnia.
What is the current status of trial NCT00784875?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 643 participants. The study started on 2008-10. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00784875?
The interventions under investigation include: Placebo (DRUG), zolpidem (DRUG), LY2624803 (DRUG).
Who is sponsoring clinical trial NCT00784875?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.